Nicholas Edwards
Co-founder @ Oxford Medical Products
Oxford, United Kingdom
Nicholas Edwards is a seed investor at Oxford Medical Products in Oxford focused on Medical and Health Care. Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Nicholas Edwards invests in
Stages Nicholas Edwards invests in
Countries Nicholas Edwards invests in
Investment Focus
Industry
- Medical 1 (50%)
- Health Care 1 (50%)
- Life Science 1 (50%)
Stage
- Seed 1 (50%)
- Venture - Series Unknown 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Oxford Medical Products
|
Oxford Medical Products is developing a safe, effective and affordable breakthrough technology for weight loss that uses a self-expanding capsule which occupies space in the stomach, reducing hunger and leading to significant weight loss. Led by a team of scientists, medical professionals, and entrepreneurs who have come together to solve one ofthe world’s toughest and most urgent medical challenges. | $3.3M / Venture - Series Unknown / Mar 09, 2022 | |
|
Oxford Medical Products
|
Oxford Medical Products is developing a safe, effective and affordable breakthrough technology for weight loss that uses a self-expanding capsule which occupies space in the stomach, reducing hunger and leading to significant weight loss. Led by a team of scientists, medical professionals, and entrepreneurs who have come together to solve one ofthe world’s toughest and most urgent medical challenges. | $1.6M / Seed / Mar 24, 2021 |
Co-Investors
Ada Ventures
2 deals together
Selvedge Venture
2 deals together
Nesta
1 deal together
Oxford Innovation
1 deal together
Verve Ventures
1 deal together
Verve Ventures
1 deal together
About Oxford Medical Products
Oxford Medical Products is developing a safe, effective and affordable breakthrough technology for weight loss that uses a self-expanding capsule which occupies space in the stomach, reducing hunger and leading to significant weight loss. Led by a team of scientists, medical professionals, and entrepreneurs who have come together to solve one ofthe world’s toughest and most urgent medical challenges.
Oxford Medical Products Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Camilla Easter
Chief Executive Officer
|
|||
Hutan Ashrafian
Chief Medical Officer
|
|||
|
Nicholas Edwards
Co-founder
|
|||
Robert Thong
Non Executive Director
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Nicholas Edwards invest in?
Nicholas Edwards invests primarily in Medical, Health Care and Life Science startups, most often at Seed and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Nicholas Edwards last invest?
The most recent investment recorded for Nicholas Edwards closed in Mar 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
